Adagio Medical Inc.

ADGM | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.47

-$0.03 (-6.56%)

Sep 22, 2026, 2:36 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $11.17M

Enterprise Value $28.98M

Beta -0.19

Average Volume 90.87K

Shares Outstanding (Diluted) 22.21M

Shares Change YoY 44.4%

Institutional Ownership 70.50%

Exchange NASDAQ

ISIN US00534B1008

Price Performance

Price Change 1M -25.0%

Price Change 3M -29.7%

Price Change 6M -57.5%

Price Change YTD -55.6%

Price Change 1Y -73.6%

Price Change 3Y -94.1%

Price Change 5Y -94.1%

1M CAGR (ann.) -26.4%

1Y CAGR (ann.) -72.4%

5Y CAGR (ann.) N/A

All-Time CAGR -74.1%

Valuation

PE Ratio -0.34

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.05

PS Ratio N/A

Forward PS 7.00

PB Ratio -25.82

P/FCF Ratio -0.66

P/Adj. FCF Ratio -0.65

P/OCF Ratio -0.65

EV/Sales N/A

EV/EBIT -1.21

EV/EBITDA -1.25

EV/FCF -1.79

Earnings Yield -297.9%

FCF Yield -151.1%

Adj. FCF Yield -155.0%

Financial Health

Net Debt $17.1M

Total Debt $26M

Cash & Short-Term Investments $7.74M

Total Assets $33.88M

Current Ratio 1.41

Quick Ratio 1.15

Debt / Equity Ratio -62.65

Debt / EBITDA -1.12

Debt / FCF -1.61

OCF / Debt -0.64

Interest Coverage -6.38

Altman Z-Score -6.55

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -2.6%

Returns

Return on Assets -80.1%

Return on Equity -661.9%

Return on Invested Capital -74.7%

Return on Capital Employed -75.3%

Return on Tangible Assets -209.6%

Historical Growth (CAGR)

Revenue CAGR 3Y -83.0%

Revenue CAGR 5Y -22.4%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 2.1%

EPS CAGR 5Y -34.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y 11.4%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -24.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.25

EPS Growth Est (next Q) -62.6%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $3

Price Target Upside 525.0%

Cash Flow

Operating Cash Flow $-16.53M

Free Cash Flow $-16.2M

Adj. Free Cash Flow $-16.61M

FCF Per Share -$0.73

OCF Per Share -$0.74

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-89K

Operating Income $-19.82M

EBITDA $-23.19M

Net Income $-27.14M

EPS (Diluted) -$1.43

Revenue / Employee N/A

Profit / Employee $-661.85K

Employees 41